Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
free free
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Reviewing ligand-based rational drug design: the search for an ATP synthase inhibitor Lee CH; Huang HC; Juan HFInt J Mol Sci 2011[]; 12 (8): 5304-18Following major advances in the field of medicinal chemistry, novel drugs can now be designed systematically, instead of relying on old trial and error approaches. Current drug design strategies can be classified as being either ligand- or structure-based depending on the design process. In this paper, by describing the search for an ATP synthase inhibitor, we review two frequently used approaches in ligand-based drug design: The pharmacophore model and the quantitative structure-activity relationship (QSAR) method. Moreover, since ATP synthase ligands are potentially useful drugs in cancer therapy, pharmacophore models were constructed to pave the way for novel inhibitor designs.|*Drug Design[MESH]|*Ligands[MESH]|Binding Sites[MESH]|Enzyme Inhibitors/*chemistry/metabolism[MESH]|Humans[MESH]|Hydrophobic and Hydrophilic Interactions[MESH]|Mitochondrial Proton-Translocating ATPases/antagonists & inhibitors/*chemistry/metabolism[MESH]|Models, Molecular[MESH]|Protein Binding[MESH]|Protein Subunits[MESH]|Quantitative Structure-Activity Relationship[MESH] |